News & events.

Our news.

Filter by Category
Filter by Year
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
News
November 2, 2021
2021

Lilly to Supply 614,000 Additional Doses of AbCellera-Discovered Bamlanivimab Together with Etesevimab to the U.S. Government for the Treatment or Post-Exposure Prevention of COVID-19

Read article
News
October 14, 2021
2021

AbCellera to Report Third Quarter 2021 Financial Results on November 9, 2021

Read article
News
September 22, 2021
2021

AbCellera and Everest Medicines Announce Multi-Target Collaboration to Advance New Antibody Therapies

Read article
News
September 21, 2021
2021

Lilly to Supply the EU and EEA with up to 220,000 Doses of Bamlanivimab Together with Etesevimab for the Treatment of Confirmed COVID-19

Read article
News
September 16, 2021
2021

Emergency Use Authorization of AbCellera-Discovered Bamlanivimab Administered with Etesevimab Expanded by the FDA to Include Post-Exposure Prophylaxis for the Prevention of COVID-19

Read article
News
September 15, 2021
2021

AbCellera Announces Collaboration with Moderna to Discover Therapeutic Antibodies for mRNA Medicines

Read article
News
September 13, 2021
2021

AbCellera Acquires TetraGenetics, Enhancing Capabilities to Generate Antibodies Against High-Value Targets

Read article
News
September 10, 2021
2021

AbCellera to Present Virtually at the BofA Securities & Tech Solutions for Drug Discovery Conference

Read article
Event
August 21, 2021
2021

Antibody Engineering & Therapeutics US 2021

Read article
Event
August 21, 2021
2021

PEGS Europe 2021

Read article